CFN Media Exclusive Interview with NanoSphere Health Sciences President and COO Mr. David Sutton
President & COO David Sutton interview with Marijuana Times
CFN sat down with NanoSphere Health Sciences COO David Sutton at the recent Seed to Sale show in Denver Colorado.
As research into cannabis has grown, the demand for new and innovative delivery methods has exploded. NanoSphere Health Sciences (NSHS.CN) (CSE:NSHS) (CNSX: NSHS) is disrupting the space through its innovative delivery systems,
NanoSphere Health Sciences’ Cannabis Brand Now Available in Over 100 Dispensaries in Colorado
Tune in to @MarijuanatimesX latest #podcast episode to hear President & COO @davidrsutton discuss the benefits of our delivery system
03-08-2018 Video News – The Marijuana Times Show
Joe Klare discusses final regulations for recreational marijuana in Massachusetts, a case in Texas involving a father giving his autistic daughter medical cannabis and an interview with David Sutton from NanoSphere Health Sciences.
WATCH THE FULL PODCAST HERE
NanoSphere pioneering innovative cannabinoid delivery technology
Evolve Formulas’ Transdermal NanoSerum™ Continues to Expand
DENVER (March 7, 2018) – NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC: NSHSF) cannabis product brand Evolve Formulas is now stocked in over 100 dispensaries throughout Colorado. The company’s pioneering product, Transdermal NanoSerum™, uses the NanoSphere Delivery System™ developed by the biotechnology firm to allow cannabis to enter systemic circulation within ten minutes for fast-acting, effective relief from pain, inflammation and anxiety. This milestone comes on the back of continuous growth, with the company recently signing a licensing agreement in California.
Taking Cannabinoid Absorbency to the Max
DR. LUC DUCHESNE
NanoSphere Health Sciences Inc. (CSE: NSHS) has developed an innovative delivery technology that increases up to six-fold the bioavailability of cannabinoids, marking a significant step forward in the medical cannabis sector.
NanoSphere Health Offers Six-Fold Improvement in Cannabinoid Bioavailability
NanoSphere’s novel retail products and technology present maximum absorbency of cannabinoids for consumers.
NanoSphere Health Sciences Inc. Increases Capacity at Key Colorado Production Facility
The U.S. cannabis industry is projected to exceed $50 billion in size over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis in California and other states. While there are many opportunities for investors in the space, since they generate high-margin licensing revenue and don’t touch the plant, biotech firms developing innovative delivery mechanisms offer investors a compelling opportunity.
NanoSphere Health Sciences Presentation Now Available for On-Demand Viewing
Demand for the Company's Groundbreaking Transdermal Evolve NanoSerum™ Driving Production
NanoSphere Health Sciences Inc. Is Nominated For NCIA's Excellence In Technology Award And Recieves OTC Trading Symbol
NanoSphere Health Sciences Inc., based in Denver, focused on nutraceuticals & supplements, cannabis, pharmaceuticals, OTCs, cosmetics, and animal health products, today announced that the January 18 presentation from Victor Goncalves, Executive Vice President, and Dr. Richard Kaufman, Chief Science Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.
NanoSphere Health Sciences Inc. (Formerly Corazon Gold Corp.) Announces Name Change, CSE Listing And Conversion Of $5.9m In Subscription Receipts
NanoSphere Health Sciences Inc. (CSE: NSHS, "NanoSphere") is pleased to announce that it has been nominated for the National Cannabis Industry Association's Excellence in Technology Award in Infused Products and Extraction.
Corazon and NanoSphere Announce Completion of $5.9 Million Financing and Merger
NanoSphere Health Sciences Inc. (CSE: NSHS) ("NanoSphere") (formerly Corazon Gold Corp.) is pleased to announce a name change and listing on the Canadian Securities Exchange (the "CSE"), effective today. NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".
Can Cannabis Replace Benzodiazepines For Anxiety Disorders?
Corazon Gold Corp. (the “Company”) and NanoSphere Health Sciences, LLC (“NanoSphere”) are pleased to announce the closing of the Company’s private placement (the “Offering”) for gross proceeds of $5,905,685, and the completion of the Company’s acquisition (the “Acquisition”) of NanoSphere.
Why Testing? Research Benefits Cannabis Consumers
According to the Anxiety and Depression Association of America, approximately 18 percent of Americans suffer from some form of anxiety disorder.
Evolve Formula’s NanoSerum™ Wins the 2017 Dope Cup Award for Best Transdermal
The commercial sale of marijuana products began in 2014, following the historic vote in Colorado and Washington in November of 2012. The economic impact has been significant and wide-spread throughout the two states ever since. Now in 2017, we are up to eight states that have legalized marijuana for recitational use, and 20 others where marijuana is legalized for medical use.
Evolve Formulas Launches Industry-First Cannabis Transdermal Product Utilizing NanoSphere Delivery System™
On August 20th, Evolve’s NanoSerum™ won the 2017 Dope Cup award from Dope Magazine for best transdermal. Dope Magazine is distributed in every dispensary in Colorado, Arizona, California, Oregon, Washington, and Nevada.
Signed Binding Merger Announcement for 100% Acquisition by Corazon Gold Corp.
Evolve Formulas, LLC, today announced the launch of their first cannabis product NanoSerum™. NanoSerum™ is the world’s first and only clinically-tested transdermal cannabis product to relieve pain and anxiety in mere minutes compared to hours with other alternative delivery methods.
How Bioavailability Will Change The Marijuana Game
We are pleased to announce that we have completed our due diligence and have signed a Binding Merger Agreement dated May 18th, 2017 with Corazon Gold Corp. (CGW: TSX-V) for 100% acquisition of NanoSphere’s issued and outstanding shares.
Solving the Opiod Painkiller Epidemic
Current delivery methods are inferior, but great things are coming.
Colorado and Washington became the first states to legalize cannabis for recreational use in 2012, since then, six others have followed suit, and more are sure to come.
NanoSphere Signs LOI for 100% Acquisition by Corazon Gold Corp (TSX Venture: CGW)
Opioids are one of the most commonly prescribed medicine to treat severe chronic pain.
- Addiction to and abuse of pharmaceutical opiates is a widespread and growing health issue
We are pleased to announce that we have signed a Letter of Intent dated December 22, 2016, with Corazon Gold Corp. (TSX VENTURE: CGW) for 100% acquisition of NanoSphere’s issued and outstanding shares.